{"id":255,"date":"2008-02-26T00:00:00","date_gmt":"2008-02-26T00:00:00","guid":{"rendered":"http:\/\/www.innovationanthology.com\/import\/2018\/02\/01\/innovation-anthology-111-president-and-ceo\/"},"modified":"2018-02-25T21:29:51","modified_gmt":"2018-02-25T21:29:51","slug":"innovation-anthology-111-president-and-ceo","status":"publish","type":"post","link":"http:\/\/www.innovationanthology.com\/import\/2008\/02\/26\/innovation-anthology-111-president-and-ceo\/","title":{"rendered":"Innovation Anthology #111: President and CEO"},"content":{"rendered":"<p><a href=\"http:\/\/innovationanthology.com\/uploads\/innovation anthology 111.mp3\">Download MP3 Link<\/a><\/p>\n<p> Huntington&rsquo;s disease is an inherited, neuro-generative disorder that usually manifests in a patient&rsquo;s 30&rsquo;s or 40&rsquo;s.   <\/p>\n<p> The mutant gene that causes Huntington&rsquo;s was identified several years ago.  And pharmocologist Dr. Simonetta Sipione was part of a group in Milan, Italy that recently  discovered a link between Huntington&rsquo;s and cholesterol.   <\/p>\n<p> Now at the University of Alberta as a Heritage Scholar, Dr. Sipione is trying to understand why the production of cholesterol is impaired in the brains of Huntington&rsquo;s patients.     <\/p>\n<p> <strong> DR. SIMONETTA SIPIONE:  <\/strong><em> So impairment of the production of lipids may be a very important and relatively early event in the development of the disease.    So right now, we are specificially looking at how cells in Huntington&rsquo;s  brains communicate with each other and how we can restore normal communication by modulating the amount of these special lipids and cholesterol that are important for cell to cell communication.   <\/em> <\/p>\n<p> As Dr. Sipione explains, it will still take a cocktail of new drugs to treat Huntington&rsquo;s patients.   <\/p>\n<p> <em> Thanks today to the <strong>Alberta Heritage Foundation for Medical Research.  <\/strong><\/em> <\/p>\n<p> <strong>FOR INNOVATION ANTHOLOGY, I&rsquo;M CHERYL CROUCHER<\/strong><\/p>\n<p><strong><br \/><\/strong><\/p>\n<p><span style=\"font-weight: bold;\">NOTE: &nbsp;The former AHFMR is now called Alberta Innovates Health Solutions<\/span><\/p>\n<h2>Guest<\/h2>\n<h3>Bob Mroz, <\/h3>\n<h4>HY-TEK Bio, Dayton, Maryland, United States, <\/h4>\n<h2>Sponsor<\/h2>\n<h3><a href=\"http:\/\/www.aihealthsolutions.ca\">Alberta Innovates Health Solutions<\/a><\/h3>\n<p><font size=\"3\"><span style=\"font-weight: bold;\">Alberta Innovates (formerly Alberta Innovates &ndash; Health Solutions) <\/span><\/font><\/p>\n<p>As the newly formed Alberta Innovates corporation, we still fund top  quality, internationally competitive health&nbsp;research and innovation  activities to improve the health and wellbeing of Albertans.&nbsp;We provide  leadership for Alberta&rsquo;s health research and&nbsp;innovation enterprise by  directing, coordinating, reviewing, funding and supporting&nbsp;research and  innovation.<\/p>\n<p>Working&nbsp;with our many partners&nbsp; in the health system, we ensure that research achieves innovation  in&nbsp;care, policy and practice, and that the needs of patients and  clinicians influence&nbsp;research.<\/p>\n<h3>Our&nbsp;background<\/h3>\n<p><a href=\"http:\/\/albertainnovates.ca\/\" target=\"_blank\">Alberta Innovates<\/a> consolidation was launched November 1, 2016.<\/p>\n<p><strong>Alberta Innovates &ndash; Health Solutions<\/strong><\/p>\n<p>Alberta Innovates &ndash; Health Solutions was established as part of the Alberta Innovates system by an Act of Legislation of the Government of Alberta. It is a agency&nbsp;  of the Government of Alberta.&nbsp;We receive a yearly allocation from the  Ministry of Health and report through the ministry to the people of  Alberta.<\/p>\n<p>Our Mandate and Roles document reflects our role and responsibilities and outlines the government statues and regulations with which we comply.<\/p>\n<p>Alberta&rsquo;s Health Research and Innovation Strategy (AHRIS) sets out  Alberta&rsquo;s health research agenda for the coming decade to ensure our  considerable investments in research align with our priority&mdash;to improve  the health of Albertans.<\/p>\n<p>&nbsp;<\/p>\n<div class=\"et_pb_module et-waypoint et_pb_image et_pb_animation_off et_pb_image_3 et_always_center_on_mobile et_pb_image_sticky et-animated\"> \t\t\t\t<img decoding=\"async\" alt=\"\" src=\"http:\/\/albertainnovates.ca\/wp-content\/uploads\/2016\/10\/health_solutions_v2_icon.png\" \/> \t\t\t \t\t\t<\/div>\n<div class=\"et_pb_text et_pb_module et_pb_bg_layout_light et_pb_text_align_left  et_pb_text_2\">\n<p><strong>780-423-5727<br \/>Toll free: 1-877-423-5727<br \/><a href=\"http:\/\/aihealthsolutions.ca\">aihealthsolutions.ca<\/a><\/strong><\/p>\n<p>1500,<br \/>10104 &ndash; 103 Avenue<br \/>Edmonton, Alberta, Canada<br \/>T5J 4A7<\/p>\n<\/div>\n<p><img decoding=\"async\" src=\"http:\/\/innovationanthology.com\/uploads\/AI Health_AHFMR Tagline_RGB.jpg\" \/><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Program Date:<\/strong>\u00a02008-02-26<\/p>\n","protected":false},"excerpt":{"rendered":"<p><strong>Huntington&rsquo;s disease<\/strong> is an inherited, neuro-generative disorder that usually manifests in a patient&rsquo;s 30&rsquo;s or 40&rsquo;s.   The mutant gene that causes Huntington&rsquo;s was identified several years ago.  And pharmocologist<strong> Dr. Simonetta Sipione<\/strong> was part of a group in Milan, Italy that recently  discovered a link between Huntington&rsquo;s and <strong>cholesterol.&nbsp;<\/strong><\/p>\n<div><strong><br \/><\/strong><\/div>\n<div><strong><br \/><\/strong><\/div>\n<div><span style=\"font-weight: bold;\">NOTE: &nbsp;The former AHFMR is now called Alberta Innovates Health Solutions<\/span><\/div>\n","protected":false},"author":1,"featured_media":256,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5,55,2],"tags":[],"class_list":["post-255","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-alberta","category-alberta-innovates-health-solutions","category-health-and-medicine","has-post-title","has-post-date","has-post-category","has-post-tag","has-post-comment","has-post-author",""],"jetpack_featured_media_url":"http:\/\/www.innovationanthology.com\/import\/wp-content\/uploads\/2018\/02\/255simonetta_sipione.jpg","_links":{"self":[{"href":"http:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/posts\/255","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/comments?post=255"}],"version-history":[{"count":4,"href":"http:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/posts\/255\/revisions"}],"predecessor-version":[{"id":4429,"href":"http:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/posts\/255\/revisions\/4429"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/media\/256"}],"wp:attachment":[{"href":"http:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/media?parent=255"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/categories?post=255"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/tags?post=255"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}